Close Menu

Bayer CropScience

HitGen will apply its DNA-encoded library design, synthesis, and screening platform to discover novel leads for Bayer research endeavors.

The yet-to-be-named entity will draw on the partners' respective resources in synthetic biology and plant and agricultural products.

The two companies will use KeyGene's technology for the genetic analysis of field and vegetable crops.

A draft sequence of a diploid A cotton genome released yesterday will lay the groundwork for sequencing the tetraploid genome of widely cultivated cotton species.

NEW YORK (GenomeWeb) – Bayer CropScience today said that it is investing almost $1 billion in capital expenditures in the US between 2013 and 2016 to build up its R&D capabilities and expand its supply of crop protection brands.

NEW YORK (GenomeWeb) – Evogene today said that its collaboration with Bayer CropScience for wheat improvement has been amended to focus on novel genomic promoters from a prior focus on the discovery of additional genes and SNPs.

NEW YORK (GenomeWeb) – Bayer CropScience has licensed Persephone, a genome browsing application developed by Ceres, an agricultural biotechnology and seed company.

NEW YORK (GenomeWeb News) – Bayer CropScience and Targenomix have inked a research collaboration agreement to use systems biology approaches to investigate metabolic and regulatory networks in plants.

NEW YORK (GenomeWeb News) – Bayer CropScience said today it has inked two agreements with Cellectis plant sciences that extend a partnership focused on modifying and editing plant genes and genomes to improve crops.

NEW YORK (GenomeWeb News) – The International Wheat Genome Sequencing Consortium will receive roughly €1 million ($1.4 million) from Bayer CropScience over the next six months to complete a wheat genome sequencing and mapping project.

Pages

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.